TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever 
KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event 
Ciscom Corp. Announces Results of Its Annual Shareholders’ Meeting 
Digital Lifestyle Expert Mario Armstrong and News Media Group, Inc. Reveal Top Tech Gifts for the Holidays in 2025 on a Nationwide Satellite Media Tour Tauriga Sciences Inc. Officially Launches Two New Product Offerings on its E-Commerce Platform (www.taurigum.com)
02_19_2021 Press Release image Image of Rainbow Bath Bomb Special The Company’s Two Newest Product…
Ayala Pharmaceuticals Announces $25 Million Strategic Financing
Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023 Funds Expected to Support…
Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting
Single-dose treatment of PHA121 demonstrated effective bradykinin inhibition in healthy volunteers ZUG, Switzerland, Feb. 19,…
Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE…
Y-mAbs to Announce 2020 Financial and Operating Results on February 25, 2021
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from…
CEO of Longeveron Inc. to Present at the Intercontinental Summit on Aging & Gerontology
MIAMI, Feb. 19, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Intercept to Present at Upcoming Investor Conferences
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
Chugai obtains exclusive development and marketing rights for AT-527 in Japan from Roche, who has…
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
GBT Announces Participation in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform
Partnerships will use Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody…
BridgeBio Pharma and Affiliate ML Bio Solutions Announce Dosing of First Patient in Phase 2 Trial of BBP-418 in Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)
SAN FRANCISCO, Feb. 19, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company…
Assembly Bio Announces Upcoming Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
Clene Nanomedicine to Present Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
SALT LAKE CITY, Feb. 19, 2021 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates
Study Led by Gene Therapy Program at the University of Pennsylvania Published in Molecular Therapy…